Clinical Trial Detail

NCT ID NCT03366844
Title Pilot; Open Label; Breast Cancer; Preoperative Pembrolizumab + Radiation
Recruitment Recruiting
Gender female
Phase Phase I
Variant Requirements Yes
Sponsors Alice Ho
Indications

estrogen-receptor positive breast cancer

triple-receptor negative breast cancer

Therapies

Pembrolizumab

Age Groups: adult senior

Additional content available in CKB BOOST